Illumina Inc ILMN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 09/24/21 EDT
432.82UNCH (UNCH)
Volume
59,605
Close
432.82quote price arrow down-0.38 (-0.09%)
Volume
751,898
52 week range
267.10 - 555.77
Loading...
  • Open431.28
  • Day High436.95
  • Day Low427.10
  • Prev Close433.20
  • 52 Week High555.77
  • 52 Week High Date02/12/21
  • 52 Week Low267.10
  • 52 Week Low Date09/24/20

Key Stats

  • Market Cap63.495B
  • Shares Out146.70M
  • 10 Day Average Volume0.92M
  • Dividend-
  • Dividend Yield-
  • Beta0.92
  • YTD % Change16.98

KEY STATS

  • Open431.28
  • Day High436.95
  • Day Low427.10
  • Prev Close433.20
  • 52 Week High555.77
  • 52 Week High Date02/12/21
  • 52 Week Low267.10
  • 52 Week Low Date09/24/20
  • Market Cap63.495B
  • Shares Out146.70M
  • 10 Day Average Volume0.92M
  • Dividend-
  • Dividend Yield-
  • Beta0.92
  • YTD % Change16.98

RATIOS/PROFITABILITY

  • EPS (TTM)5.20
  • P/E (TTM)83.16
  • Fwd P/E (NTM)104.29
  • EBITDA (MRQ)869.00M
  • ROE (MRQ)15.77%
  • Revenue (MRQ)3.966B
  • Gross Margin (MRQ)68.63%
  • Net Margin (MRQ)19.36%
  • Debt To Equity (MRQ)32.41%

EVENTS

  • Earnings Date10/27/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Illumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions. The Company operates through segments such as Core Illumina. Core Illumina’s products and services serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. Core Illumina consists of its core operations. The Company's portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed for genetic...
John Thompson
Non-Executive Chairman
Francis deSouza
President
Robert Ragusa
Chief Operating Officer
Sam Samad
Chief Financial Officer
Alex Aravanis M.D., Ph.D.
Chief Technology Officer
Jose Torres Jr., CPA
Chief Accounting Officer
Charles Dadswell
General Counsel
Address
5200 Illumina Way
San Diego, CA
92122-4616
United States

Top Peers

SYMBOLLASTCHG%CHG
CRL
Charles River Laboratories International Inc
458.30+3.26+0.72%
BNTX
BioNTech SE
333.48-19.51-5.53%
INCY
Incyte Corp
69.00-0.78-1.12%
SYNH
Syneos Health Inc
96.31+0.29+0.30%
GMAB
Genmab A/S
43.43-1.45-3.23%